Reglan

Do you want an attorney on your side who has been recognized as one of Dallas/Fort Worth's best lawyers? Rachel Montes will ensure that you will not stand alone in your legal battle. The best legal counsel and affordable help is just one phone call away.

"We have a well-earned reputation for building strong cases and taking them all the way through jury trial when necessary."

Rachel Montes

TARDIVE DYSKINESIA LINKED TO REGLAN USE

ReglanLong term or high dosage use of Reglan (also known as metoclopramide), has been linked to a movement disorder called tardive dyskinesia, which can continue to affect Reglan users even after the drug is discontinued.

In February of 2009, the U.S. Food & Drug Administration (FDA) ordered the maker of Reglan to add a boxed warning about this risk to its label. In lawsuits filed against Wyeth, the manufacturer of Reglan, allegations have been made that Wyeth knew of a widespread tendency among physicians to mis-prescribe Reglan for long periods of time even though the medication is only approved for 12 months of use. REGLAN IS ONLY APPROVED FOR SHORT TERM USE OF PERIODS BETWEEN 4-12 WEEKS.

Click here to read the FDA Warning.

ReglanREGLAN is supposed to be prescribed as a short-term treatment for heartburn caused by gastroesophageal reflux in people who have used other medications without relief of symptoms. REGLAN is also used to treat slow gastric emptying in people with diabetes (also called diabetic gastroparesis), which can cause nausea, vomiting, heartburn, loss of appetite, and a feeling of fullness after meals.

In one study, the FDA found that about 20 percent of patients who used REGLAN, used it for longer than three months, longer than the 12 week period alloted for use of the product. The FDA also claims there were reports of TARDIVE DYSKINESIA in patients who used REGLAN (metoclopramide), and that the majority of those who reported these problems had taken the drug for more than three months.

WHAT IS TARDIVE DYSKINESIA?

Tardive Dyskinesia is horribly disabling condition that is characterized by repetitive, involuntary movements much like Parkinson's, but often times much more pronounced than Parkinsons. Even after the patient stops taking the medication, the side effects not only continue, but in many cases the symptoms actually worsened after the patient discontinued the use of REGLAN. To make matters worse, there is no treatment an no cure for TARDIVE DYSKINESIA.

  1. Were you or a loved one prescribed Reglan® or Metoclopramide?
  2. Have you or loved one been diagnosed with Tardive Dyskinesia?
  3. How long did you or your loved one take Reglan® or Metoclopramide?
  4. Did you or loved one experience any of the following symptoms?
    1. Involuntary/ repetitive movements of the extremities
    2. Facial tics
    3. Lip smacking, pursing and puckering
    4. Face Grimacing
    5. Tongue protrusion
    6. Rapid eye movements or blinking
    7. Impaired movement of the fingers.
    8. Restless Leg Syndrome (RLS)

FREE CASE REVIEW

FDA Warning for Reglan

2009's Most Dangerous Toys | Dallas, Texas Personal Injury Attorney Blog

By Team Member | November 18, 2009

Two consumer watchdog groups have released their lists of dangerous toys. The World Against Toys Causing Harm (W.A.T.C.H.), released is annual list of the 10 worst children’s toys, while the Center for Environmental Health released its list of toys they believe have dangerous levels of lead paint. WATCH’s list of toys typically have a choking…

Internal Emails From Insurance Company Describe Intentional Wrongful Denials of Claims | Dallas, Texas Personal Injury Attorney Blog

By Team Member | November 12, 2009

A lawsuit filed in Galveston accuses the Texas Windstorm Insurance Association (TWIA) of using prices below market rate to under-pay claims by under-estimate damages its insureds sustained as a result of Hurricane Ike. In addition, the lawsuit claims that the insurance company unfairly limited the costs allowed on roof damage claims, and discouraged re-opening closed…

Medical Journal Accuses Pfizer of Skewing Test Data | Dallas, Texas Personal Injury Attorney Blog

By Team Member | November 12, 2009

A report in the New England Journal of Medicine is expected to show that the drug manufactuer Pzifer, skewed test data to make its test results on Neurontin look more favorable. Neurontin is primarily used to treat epilepsy, and is being marketed by Pfizer for treatment for uses that have not yet been approved. The…

Ways to Get in Touch

Please enter your name.
Please enter a valid phone number.
Please enter a message.

PHONE: 214-522-9401
FAX: 214-522-9428
CALL TOLL FREE: 877-529-8899

MONTES LAW GROUP, PC
1121 KINWEST PARKWAY, SUITE 100
IRVING, TX 75063

Street View